Cervical Mass
A cervical mass is any lump, growth, or focal abnormality of the cervix, found either during a pelvic examination or on imaging. The causes range from entirely harmless to serious, and the distribution is reassuring: cervical polyps and nabothian cysts are common and benign, while cancer accounts for a small minority. Because the cervix is directly visible and accessible, the evaluation is usually straightforward—examination establishes the appearance, and biopsy resolves anything uncertain. The one principle that matters throughout is that a visible cervical lesion should be assessed on its own merits, and a recent normal screening result does not substitute for looking at a lesion that can be seen.
What is it?
The cervix is the lower portion of the uterus, projecting into the top of the vagina, with a narrow canal running through it. Its outer surface, visible on examination, is covered by flat squamous cells like those of the vagina, while the canal is lined by column-shaped glandular cells that produce mucus. The junction between these two cell types—the transformation zone—shifts position across a woman’s life under hormonal influence, and understanding this movement explains several of the common benign findings.
Cervical mass is a descriptive term rather than a diagnosis, covering anything from a normal variant to a cancer. The evaluation is one of characterisation, and the reassuring context is that benign causes are far more common.
Nabothian cysts are the most frequent finding and are essentially normal. As the transformation zone moves, squamous cells grow over the mucus-producing glands and trap their secretions, forming smooth, round, fluid-filled cysts on the cervical surface. They may be single or numerous, range from a few millimetres to occasionally a couple of centimetres, and appear as smooth yellowish or translucent bumps. They cause no symptoms, require no treatment, and are not precancerous. They appear frequently on ultrasound reports, where the phrase can sound alarming to a woman reading it, and the accurate description is that they are a normal consequence of how the cervix remodels itself.
Cervical polyps are the most common actual growth. They are soft, smooth, finger-like or teardrop-shaped projections, usually red or purplish, arising from the canal or the surface and often visible protruding through the cervical opening. They are benign in the great majority, with malignancy found in well under 1% of those removed. They commonly cause bleeding after intercourse or between periods, because their surface is fragile and bleeds easily on contact, and they may cause discharge. They are most common in women in their forties to sixties and in those who have had children.
Cervical ectropion, sometimes called cervical erosion—a misleading term, since nothing is eroded—occurs when the glandular cells from inside the canal extend onto the outer surface. This is a normal hormonal response seen in younger women, in those taking combined hormonal contraception, and in pregnancy. The exposed glandular tissue appears red and is more fragile than squamous tissue, which is why it commonly causes bleeding after intercourse and increased mucus discharge. It is entirely benign and is not a precursor to anything.
Cervical fibroids are benign muscular growths arising in the cervix rather than the body of the uterus. They account for a small proportion of fibroids overall but can be clinically significant because of their position, potentially causing pressure symptoms, obstructing labour, or complicating surgery.
Cervicitis is inflammation of the cervix, most often from infection including chlamydia, gonorrhoea, trichomonas, or herpes, and produces a red, swollen, friable cervix with discharge that can be mistaken for a mass or a suspicious lesion. Identifying and treating infection is important both for the woman and for partner notification.
Endometriosis can involve the cervix, producing small bluish or reddish deposits that may bleed cyclically.
Other benign lesions include mesonephric remnants, cervical endometriotic cysts, and rarely condylomata from HPV infection appearing as warty growths.
Precancerous change—cervical intraepithelial neoplasia—is typically not visible as a discrete mass and is usually identified through screening rather than as a lump. It matters here because it can coexist with visible benign lesions and because colposcopy assesses for it.
Cervical cancer is the diagnosis the evaluation exists to exclude. It may appear as an irregular, raised, ulcerated, or cauliflower-like growth, or as an area that bleeds readily on contact. It can also grow within the canal and expand the cervix without producing an obvious surface lesion—a pattern described as a barrel-shaped cervix, which can be missed on visual inspection alone and is one reason a cervix that feels abnormally bulky warrants imaging even when the surface looks unremarkable. Adenocarcinoma in particular tends to arise higher in the canal and may be less visible.
Rarer malignancies include cervical sarcoma, lymphoma involving the cervix, and metastatic deposits, most often from endometrial cancer extending downward.
Symptoms are frequently absent, and many cervical masses are found incidentally at a routine examination or screening appointment.
Where symptoms occur, abnormal bleeding is the most common—after intercourse, between periods, or after menopause. Postcoital bleeding is a particularly characteristic symptom of cervical lesions of all kinds, benign and malignant, because the cervix is directly contacted during intercourse and abnormal tissue there bleeds readily.
Vaginal discharge is common, and its character varies: clear and mucoid with ectropion, purulent with infection, and watery, blood-stained, or offensive with more significant lesions.
Pelvic discomfort and pain during intercourse occur. Larger lesions can produce a sensation of pressure or of something protruding.
Features suggesting something more serious include a lesion that is irregular, hard, ulcerated, or fixed rather than mobile; one that bleeds readily on light contact; one that is enlarging; and accompanying symptoms including persistent pelvic or lower back pain, leg swelling, urinary or bowel changes, and unexplained weight loss.
Evaluation is direct, and the cervix is unusually accessible compared with most sites where masses arise.
Speculum examination allows the cervix to be seen directly. This establishes the appearance, size, surface characteristics, mobility, and whether the lesion bleeds on contact, and in many cases identifies a benign finding confidently.
One principle deserves particular emphasis. A visible or palpable cervical lesion should be assessed on its own merits, and a recent normal cervical screening result does not exclude cancer in a visible lesion. Screening tests sample cells or detect HPV; they are designed to find changes in a cervix that looks normal, not to characterise a lump that can be seen. Relying on a normal smear or HPV test to explain away a visible abnormality is a recognised route to delayed diagnosis, and this applies equally to persistent postcoital bleeding in a woman with normal screening.
Colposcopy examines the cervix under magnification, applying solutions that highlight abnormal areas, and allows targeted biopsy. It is used for abnormal screening results and for evaluating visible lesions.
Biopsy is the definitive test. The threshold should be low for any lesion that is irregular, ulcerated, friable, indurated, or persistent, and for any lesion in a woman with unexplained bleeding.
Transvaginal ultrasound characterises nabothian cysts, cervical fibroids, and lesions extending into the canal or uterine cavity, and assesses the endometrium at the same time, which matters since abnormal bleeding may arise from either site.
MRI of the pelvis provides the clearest assessment of a suspicious cervical mass, defining its size, how deeply it invades, whether it extends into the surrounding parametrial tissue, vagina, bladder, or rectum, and whether lymph nodes are involved. It is the reference standard for staging cervical cancer and is also useful for characterising large cervical fibroids before surgery.
HPV testing and cytology contribute to the overall picture, particularly for detecting associated precancerous change, but they do not replace examination and biopsy of a lesion that is visible.
Testing for sexually transmitted infections is appropriate where cervicitis is suspected.
Important to Know
Most cervical masses are benign, and many require nothing more than an explanation. The value of assessment lies in establishing which kind of lesion is present, and because the cervix can be seen and sampled directly, that question is usually answered quickly. Care is typically coordinated by primary care clinicians and gynaecologists, with colposcopy services and gynaecological oncology involved as needed.
Nabothian cysts need no treatment and no follow-up. When they appear on an ultrasound report, this is a description of normal cervical anatomy rather than a finding of concern, and they do not become cancerous.
Cervical ectropion likewise needs no treatment in most cases. Where it causes troublesome postcoital bleeding or persistent discharge, cautery or cryotherapy can be used, though it is worth confirming first that the symptoms are genuinely attributable to it and that nothing else is present. Ectropion often resolves on its own after stopping combined hormonal contraception or after pregnancy.
Cervical polyps causing bleeding are removed, usually in a simple outpatient procedure taking moments, and the tissue is sent for examination to confirm it is benign. Removal is generally recommended for symptomatic polyps, for polyps in postmenopausal women, and where there is any uncertainty about appearance. An important accompanying point is that a cervical polyp does not always explain abnormal bleeding, and polyps within the uterine cavity or endometrial pathology may coexist—so bleeding that persists after polyp removal warrants further assessment rather than being considered resolved.
Cervicitis is treated with appropriate antimicrobial therapy once the organism is identified, with testing for other sexually transmitted infections and partner notification where relevant. A cervix that remains abnormal after treating infection requires reassessment.
Cervical fibroids are treated when symptomatic, and management depends on size, position, and whether fertility is a consideration. Their location can make surgery more complex than for fibroids in the body of the uterus, and specialist input is valuable.
Where biopsy shows precancerous change, treatment is by local excision, which is highly effective and preserves the uterus. Where it shows cancer, management follows stage-directed pathways with surgery, chemoradiotherapy, or a combination, coordinated by a gynaecological oncology team.
Abnormal bleeding deserves a note of its own, because it is the symptom that most often accompanies a cervical mass and the one most likely to be dismissed. Postcoital bleeding has a benign explanation in most women—ectropion, a polyp, or infection—but it is also a classic presentation of cervical cancer, and the two cannot be distinguished by the pattern of bleeding alone. Persistent postcoital bleeding warrants examination regardless of age and regardless of screening history. Similarly, any bleeding after menopause requires investigation, and although the endometrium is the more common source, the cervix is examined as part of that assessment.
In pregnancy, the cervix becomes more vascular and ectropion is common, so bleeding from a benign cervical cause is frequent. This does not remove the need for examination, since pregnancy does not protect against cervical pathology and cervical cancer is occasionally diagnosed during pregnancy. Speculum examination is safe.
Prevention applies principally to the malignant end of this spectrum. HPV vaccination prevents infection with the types responsible for nearly all cervical cancer and is most effective when given before exposure. Participating in cervical screening detects precancerous change years before cancer develops. Stopping smoking reduces risk. These measures do not prevent polyps, cysts, or ectropion, which are not related to HPV and are not preventable in any meaningful sense.
Care is typically coordinated by primary care and gynaecology, with colposcopy, radiology, sexual health, and gynaecological oncology involvement as required. Examination, imaging, cytology, HPV status, and biopsy findings are interpreted alongside symptoms, age, and screening history rather than in isolation.
Patient education plays an important role. Understanding that most cervical lumps are benign, that nabothian cysts and ectropion are normal findings rather than disease, that a polyp causing bleeding is easily removed, that a normal screening result does not explain a visible lesion, and that persistent postcoital bleeding always warrants examination all contribute to appropriate care.
Red flag symptoms include bleeding after intercourse, particularly when persistent or recurrent; bleeding between periods or any bleeding after menopause; persistent watery, blood-stained, or offensive-smelling vaginal discharge; a cervical lesion that is irregular, ulcerated, hard, fixed, or bleeds readily on contact; persistent pelvic or lower back pain, particularly radiating into the legs; new leg swelling; difficulty or pain passing urine, or blood in the urine; a change in bowel habit; unexplained weight loss; and any of these occurring despite a recent normal screening result. These warrant prompt medical evaluation with direct examination of the cervix and biopsy of any visible lesion.